\-\ Texto\\:\\ \ \(0\)\
\-\ hyperprolactinemia\\ without\\ elevation\\ of\\ tsh\\,\\ negative\\ hcg\\,\\ no\\ history\\ or\\ symptoms\\ of\\ cirrhosis\\,\\ renal\\ failure\\.\ \(0\)\
\-\ serum\\ calcium\\ normal\ \(0\)\
\-\ multisequence\\ mri\\ imaging\\ shows\\ subcentimeter\\ within\\ the\\ pituitary\\ gland\\.\ \(0\)\
\-\ hypointense\\ to\\ pituitary\\ on\\ both\\ pre\\ and\\ post\\-contrast\\ t1\\ imaging\\.\ \(0\)\
\-\ no\\ expansion\\ of\\ the\\ sella\\ turcica\\ or\\ encroachment\\ on\\ surrounding\\ structures\\.\ \(0\)\
\-\ pituitary\\ adenoma\ \(19\)\
\-\ pituitary\\ micoadenoma\ \(0\)\
\-\ physiologic\\ cyst\ \(0\)\
\-\ rathke\\'s\\ pouch\\ cyst\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ 34\\ yo\\ white\\ female\\ with\\ oligomenorrhea\\ and\\ galactorrhea\\ without\\ any\\ significant\\ pmh\\ or\\ fh\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pituitary\\:\\ 0\\.47802161713397723\ \(0\)\
\-\ micoadenoma\\:\\ 0\\.20719002696736497\ \(0\)\
\-\ oligomenorrhea\\:\\ 0\\.20719002696736497\ \(0\)\
\-\ hyperprolactinemia\\:\\ 0\\.18223842164460793\ \(0\)\
\-\ galactorrhea\\:\\ 0\\.18223842164460793\ \(0\)\
\-\ multisequence\\:\\ 0\\.17063658587012143\ \(0\)\
\-\ fh\\:\\ 0\\.16847190774459123\ \(0\)\
\-\ subcentimeter\\:\\ 0\\.1646777870788529\ \(0\)\
\-\ turcica\\:\\ 0\\.1629946520078887\ \(0\)\
\-\ encroachment\\:\\ 0\\.15605884538073786\ \(0\)\
\-\ cyst\\:\\ 0\\.1494734415423013\ \(0\)\
\-\ physiologic\\:\\ 0\\.14807792119659322\ \(0\)\
\-\ pouch\\:\\ 0\\.14284228401451352\ \(0\)\
\-\ rathke\\:\\ 0\\.14154410612435153\ \(0\)\
\-\ without\\:\\ 0\\.136673011343964\ \(0\)\
\-\ cirrhosis\\:\\ 0\\.13647608542210668\ \(0\)\
\-\ imaging\\:\\ 0\\.1361732938743488\ \(0\)\
\-\ or\\:\\ 0\\.13521183710414486\ \(0\)\
\-\ sella\\:\\ 0\\.13408314477287786\ \(0\)\
\-\ tsh\\:\\ 0\\.12517911234488072\ \(0\)\
\-\ hcg\\:\\ 0\\.12150334489085435\ \(0\)\
\-\ elevation\\:\\ 0\\.11811444335824028\ \(0\)\
\-\ expansion\\:\\ 0\\.11811444335824028\ \(0\)\
\-\ pmh\\:\\ 0\\.11723231578538745\ \(0\)\
\-\ calcium\\:\\ 0\\.11701703521684768\ \(0\)\
\-\ serum\\:\\ 0\\.11617575644984829\ \(0\)\
\-\ hypointense\\:\\ 0\\.1140110783243181\ \(0\)\
\-\ 34\\:\\ 0\\.11291189947930848\ \(0\)\
\-\ pre\\:\\ 0\\.10589153955103103\ \(0\)\
\-\ gland\\:\\ 0\\.1052444322474027\ \(0\)\
\-\ adenoma\\:\\ 0\\.10328951176405865\ \(0\)\
\-\ failure\\:\\ 0\\.09836241351971292\ \(0\)\
\-\ structures\\:\\ 0\\.09734873116487523\ \(0\)\
\-\ surrounding\\:\\ 0\\.08640525829675774\ \(0\)\
\-\ white\\:\\ 0\\.08547811201752577\ \(0\)\
\-\ no\\:\\ 0\\.08426099734177891\ \(0\)\
\-\ any\\:\\ 0\\.08373017824374175\ \(0\)\
\-\ yo\\:\\ 0\\.08093993422827399\ \(0\)\
\-\ t1\\:\\ 0\\.08072217676023538\ \(0\)\
\-\ renal\\:\\ 0\\.0806788746881439\ \(0\)\
\-\ negative\\:\\ 0\\.08020792241480598\ \(0\)\
\-\ on\\:\\ 0\\.07825694335322982\ \(0\)\
\-\ of\\:\\ 0\\.07606126019253906\ \(0\)\
\-\ shows\\:\\ 0\\.0760388168757504\ \(0\)\
\-\ significant\\:\\ 0\\.07480342252227122\ \(0\)\
\-\ both\\:\\ 0\\.07224740921603955\ \(0\)\
\-\ metastatic\\:\\ 0\\.07105559501476126\ \(0\)\
\-\ symptoms\\:\\ 0\\.07088631276574217\ \(0\)\
\-\ mri\\:\\ 0\\.06650312575366947\ \(0\)\
\-\ female\\:\\ 0\\.0625172821710544\ \(0\)\
\-\ within\\:\\ 0\\.05967001077064209\ \(0\)\
\-\ disease\\:\\ 0\\.0543834731218461\ \(0\)\
\-\ and\\:\\ 0\\.05354278212107899\ \(0\)\
\-\ normal\\:\\ 0\\.05289730016821906\ \(0\)\
\-\ the\\:\\ 0\\.05170267665960871\ \(0\)\
\-\ history\\:\\ 0\\.04949831699040568\ \(0\)\
\-\ to\\:\\ 0\\.03238902354432892\ \(0\)\
\-\ with\\:\\ 0\\.02536890225912657\ \(0\)\
